Last fall, Johnson & Johnson settled with 6 of the males suing the company due to their affliction with gynecomastia following use of the prescription drug […]
Risperdal and Male Breast Development Taking Risperdal, the Johnson & Johnson brand of risperidone, has demonstrated an increased risk of gynecomastia (male breast growth), especially in […]
Breast Enlargement from Risperdal The Johnson & Johnson atypical antipsychotic medication, Risperdal (generic: risperidone) has been linked to an increased risk of breast enlargement in boys. […]
FDA Investigates Zyprexa Injection Deaths 06/18/2013 The Food and Drug Administration (FDA) is investigating two unexplained Zyprexa Injection deaths in patients who received an intramuscular injection […]
Zoloft is the most popularly utilized antidepressant medication around the world and has been prescribed to more than 100 million individuals in order to treat social […]
Children born with cardiac and other serious congenital birth defects have potentially been linked to use of the anti-depressant drug Effexor (venlafaxine). Research suggests serious Effexor […]
Pradaxa is a prescription anticoagulant approved by the Food and Drug Administration (FDA) for use in the United States in 2010. Pradaxa is manufactured by German […]